Today: 21 May 2026
Microsoft stock slips into year-end close as tech cools; what MSFT bulls watch next
31 December 2025
1 min read

Microsoft stock slips into year-end close as tech cools; what MSFT bulls watch next

NEW YORK, December 31, 2025, 16:18 ET — After-hours

Microsoft Corp shares (MSFT.O) were down 0.8% at $483.54 in after-hours trading on Wednesday, extending a late-day fade in heavyweight technology stocks. The shares traded between $483.30 and $488.30 during the regular session.

The stock’s decline came as Wall Street finished the final session of 2025 lower, with the S&P 500 down 0.73%, the Nasdaq down 0.76% and the Dow down 0.62% in thin year-end trading ahead of the New Year’s Day market holiday. All three benchmarks still ended 2025 up by double digits after a year dominated by investor demand for AI-linked stocks.

That matters now because Microsoft is one of the largest index weights, and small moves in megacaps can sway benchmarks in low-liquidity sessions. It also sets the tone for the first week of 2026 as investors reassess the “AI trade” — a shorthand for stocks tied to artificial intelligence spending — against interest-rate expectations and earnings outlooks.

Microsoft ended 2025 up about 16% on a total-return basis, according to Yahoo Finance data. The stock’s relative performance has kept attention on whether Microsoft can keep translating AI features into paid usage across Azure and Microsoft 365.

At Wednesday’s levels, MSFT sat roughly 13% below its 52-week high of $555.45, according to MarketWatch. Some traders use that gap to frame near-term resistance levels into the new year.

Holiday weeks can also magnify tax-driven selling and portfolio rebalancing, particularly among the biggest winners. With rates still a key swing factor for valuations, traders have been sensitive to any shift in bond yields that changes the appeal of long-duration growth stocks.

Away from Wednesday’s tape, CEO Satya Nadella has reshaped Microsoft’s leadership as it tries to push its AI strategy beyond its reliance on OpenAI, the Financial Times reported on Tuesday. “Satya is in ‘founder mode’,” deputy chief technology officer Dee Templeton told the FT. Financial Times

On the Street, Wedbush Securities analyst Dan Ives put Microsoft at the top of his AI stock picks for 2026, citing demand for Azure as companies build out AI infrastructure, Barron’s reported.

In a separate filing, Microsoft submitted a post-effective amendment on Form S-8 on Dec. 30, according to the SEC. Form S-8 is used to register shares issued under employee benefit plans, a common step for large employers with stock-based compensation.

The next major stock catalyst is Microsoft’s fiscal second-quarter results, but the company has not announced the date, its investor relations FAQ shows.

Nasdaq’s earnings calendar currently estimates Microsoft will report on Feb. 4, while noting the timing is based on historical patterns rather than a company confirmation.

Until that date is confirmed, traders are likely to keep benchmarking MSFT against other AI bellwethers on two fronts: the pace of cloud demand and any signs that rising AI infrastructure costs are stabilizing. In the near term, price action in megacap tech and moves in yields remain the main macro inputs shaping the stock’s day-to-day trade.

Stock Market Today

  • Options Traders Anticipate Significant Move in Amalgamated Financial Stock
    May 21, 2026, 10:19 AM EDT. Options market activity in Amalgamated Financial Corp. (AMAL) highlights elevated implied volatility on the May 16, 2025 $22.50 call option, signaling expectations of a major stock price movement. Implied volatility reflects anticipated market fluctuation; high levels suggest investor anticipation of a strong rally or sell-off. Despite this, Amalgamated Financial holds a modest Zacks Rank #3 (Hold) status with a neutral earnings forecast slightly lowered from 91 to 90 cents per share. Analysts have not upgraded estimates recently, dampening fundamental outlook. Some options traders may leverage high implied volatility to sell premium, speculating the stock's movement will be less extreme than forecast. The divergence between options market speculation and analyst outlook invites close attention to AMAL shares in coming months.

Latest articles

Stellantis Launches $70 Billion Overhaul With Focus on Jeep, Ram, China

Stellantis Launches $70 Billion Overhaul With Focus on Jeep, Ram, China

21 May 2026
Stellantis announced a €60 billion, five-year plan Thursday, focusing investment on Jeep, Ram, Peugeot, Fiat, and its commercial vehicles. Shares dropped over 5% in early European trading after the announcement. The company aims to launch over 60 new vehicles by 2030 and cut development cycles to 24 months. CEO Antonio Filosa is targeting 25% North American revenue growth and €6 billion in annual cost reductions.
Nike stock climbs but analysts hold back on turnaround calls

Nike stock climbs but analysts hold back on turnaround calls

21 May 2026
Nike shares climbed 3.4% to $44.07 Wednesday as falling oil prices and lower U.S. Treasury yields boosted consumer stocks. Nike reported flat quarterly revenue at $11.3 billion, with direct-to-consumer sales down 4% and net income down 35%. The company plans to launch a Google Gemini-powered shopping feature in June. Nike’s global footwear market share slipped to 22.9% in 2025, while Adidas gained, Reuters said.
Infleqtion shares react to $100 million quantum funding news in Washington

Infleqtion shares react to $100 million quantum funding news in Washington

21 May 2026
Infleqtion shares rose 5.1% premarket Thursday after the U.S. Commerce Department signed a preliminary $100 million funding letter for its neutral-atom quantum computing project, which would also give the government stock in the company. The proposed award, not yet final, is contingent on milestones and approvals. INFQ last traded at $11.18 before the New York open. D-Wave and Rigetti also saw premarket gains.
AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious
Previous Story

AI stocks today: Nvidia, AMD tick higher as year-end trade turns cautious

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop